Beyond Air Newsroom

Beyond Air Analyst Ratings

BenzingaAug 16 08:48 ET

Beyond Air Analyst Ratings

BenzingaAug 7 07:43 ET

Beyond Air Analyst Ratings

BenzingaJun 25 08:50 ET

Beyond Air Analyst Ratings

BenzingaApr 30 13:07 ET

Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating

MT NewswiresApr 30 07:19 ET

Piper Sandler Remains a Buy on Beyond Air (XAIR)

TipRanksFeb 13 07:37 ET

BTIG Remains a Buy on Beyond Air (XAIR)

TipRanksJan 2 09:55 ET

Beyond Air (XAIR) Receives a Buy From BTIG

TipRanksDec 31, 2023 05:28 ET

Truist Securities Maintains Buy on Beyond Air, Lowers Price Target to $10-Report Released on 13th Nov 2023

BenzingaNov 14, 2023 10:38 ET

Beyond Air Analyst Ratings

BenzingaNov 14, 2023 10:35 ET

Beyond Air's Stock Receives Buy Rating Amidst Promising Growth and Revenue Prospects

TipRanksNov 13, 2023 20:55 ET

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Beyond Air (XAIR) and Ovid Therapeutics (OVID)

TipRanksNov 3, 2023 14:50 ET

Truist Financial Reaffirms Their Buy Rating on Beyond Air (XAIR)

TipRanksOct 18, 2023 22:26 ET

Promising Preclinical Data Bolsters Buy Rating for Beyond Air's Stock: A Study on UNO's Potential as Cancer Immunotherapy

TipRanksOct 16, 2023 10:06 ET

Beyond Air (XAIR) Gets a Buy From Piper Sandler

TipRanksAug 11, 2023 09:16 ET

Piper Sandler Initiates Coverage On Beyond Air With Overweight Rating, Announces Price Target of $10

BenzingaJul 28, 2023 05:58 ET

Beyond Air Analyst Ratings

BenzingaJul 28, 2023 05:57 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: 2seventy Bio (TSVT), Beyond Air (XAIR) and Homology Medicines (FIXX)

TipRanksJul 28, 2023 04:40 ET

Truist Securities Maintains Buy on Beyond Air, Lowers Price Target to $14

BenzingaJul 21, 2023 10:07 ET

Beyond Air Analyst Ratings

BenzingaJul 21, 2023 10:06 ET